SEC Form D · filed February 7, 2019
Axon Therapies Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Mark R. Gelfand · New York, NYExec · DirectorImran S. Eba · New York, NYDirectorMitchell S. Bloom · New York, NYExecSteven S. Hochberg · New York, NYDirectorAndrew S. Elbardissi · New York, NYDirectorPaul S. Laviolette · New York, NYDirectorHoward R. Levin · New York, NYExec · DirectorBradley M. Anderson · New York, NYDirectorCarl J. Tippit · Cleveland, OHExecWadstrom Nicolai · San Francisco, CAExec · DirectorPatrick Ritschel · Durham, NCDirectorAdi Sideman · New York, NYDirectorBenjamin Levy · San Francisco, CAExec · DirectorDavid Pakman · New York, NYDirectorDavid Dunn · Wilton, CTDirectorNicolai Wadstrom · San Francisco, CAExec · DirectorRagan Young · Dallas, TXExec · DirectorRobert A. Granieri · New York, NYExecChris Carvalho · Tarzana, CADirectorAndre Bliznyuk · Tarzana, CADirectorSean Madnani · Los Angeles, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗